Rejoovenate Bio

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://rejoovenatebio.com/

Last Round

Series A

Extension

Jun 8, 2026

Est. Valuation

$67.38M

Total Funding Raised

$31.48M

Company Overview

Rejoovenate Bio is a biotechnology company developing laboratory-based solutions to address age-related declines in egg quality and extend female reproductive healthspan.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

fertility biotechnologyegg qualityreproductive longevityIVFin vitro fertilizationreproductive healthspanfertility techreproductive endocrinologycellular therapyfertility cliniclongevity biotechreproductive agingegg freezingbiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rejoovenate Bio Comps

Public and private peers based on sector, stage, and business model.

Rejoovenate Bio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Rejoovenate Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Jun 8, 2026
Crowdfunding	Apr 1, 2026
Grant	Jul 1, 2024
Series A	Apr 19, 2021

View all Funding Rounds

Rejoovenate Bio Investors

Notable investors and investment history

Rejoovenate Bio investors
Investor	Rounds
Kendall Capital Partners	Series A Extension, Series A
Connecticut Innovations	Series A Extension
Digitalis Ventures	Series A, Series A Extension
California Institute for Regenerative Medicine	Grant
KdT Ventures	Series A
VCapital	Series A, Series A Extension

View all Investors

Rejoovenate Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Rejoovenate Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rejoovenate Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Year Founded2025

Last FundingJun 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.